Anavex Life Sciences Corp (AVXL)

[frrol]

Almost. There is another outcome: we sufficiently pass some trials. If you want to be an investor, you need to consider all outcomes. As with human disease, drug development can be complex.

If we just pass a smaller indication, eg Rett, your few thousand shares might not be worth millions (though you'll still get an excellent return).

Ignore the pumping and bashing, folks. There's a lot of it out there.